This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Early Phase Clinical Trial Outsourcing Market

Market Insights on Early Phase Clinical Trial Outsourcing covering sales outlook, demand forecast & up-to-date key trends

Early Phase Clinical Trial Outsourcing Market: Global Industry Analysis and Opportunity Assessment 2017-2027

Early Phase Clinical Trial Outsourcing Market Overview

Clinical trials are generally conducted to collect data regarding safety and efficacy of new drugs and devices development. There are multiple stages of drug approval in clinical trial process before drug or device can be sold in the market.

In general, drugs or devices must undergo several phases of clinical trial that include preclinical, clinical trials to get market approval. Clinical trials are done on human subjects in different phases such as phase 0, phase 1, phase 2, phase 3, and phase 4 or post marketing surveillance to testify the products safety and efficacy.

Early phase clinical trials include Phase 0, Phase 1, and Phase 2 stages of clinical trials which are essential to ascertain the safety and efficacy of the drug or devices in target population. Clinical trials outsourcing in pharmaceutical and medical devices industry has been a market trend owing to increased expertise of Clinical Research Organizations (CROs) coupled cost saving strategies adopted the numerous drug development companies in the market.

Early phase clinical trial outsourcing market is driven by increasing cost associated with in house clinical trials along with drug discovery companies’ effort to improve cost efficiency of its operations. Several studies indicate that more than 50% of the early phase clinical trials are outsourced to global and speciality CROs.

In addition, increased spending on small molecules research & development, increasing investment in small biopharmaceutical companies, rising product pipelines of large pharmaceutical companies expected to boost the revenue growth of early phase clinical trial outsourcing market over the forecast period.

However, increased per-patient cost, difficulties in recruiting/retaining the subjects (patients), and sudden dropout or withdrawal of patient from the clinical trial or study may impact the market revenue growth negatively over the forecast period.

Early phase clinical trial outsourcing market is undergoing market changes due to the higher competition among key service providers who are scaling up service offering and global capabilities for gaining market share. Majority pharma companies are continuously outsourcing the clinical trials to broad range of service providers (CROs).

Non-traditional service providers will also continue to enter into the market place by means of partnership or acquisition. By trial phase type, sub segment such as phase 2 in the global early phase clinical trial outsourcing market is expected to grow in positive traction owing to comparatively larger patient pool and increased number of drug candidates in the above mentioned phase.

Geographically, early phase clinical trial outsourcing market is segmented into regions viz. North America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America and Europe region is projected to maintain its lions share over the forecast period.

Advanced healthcare infrastructure, availability of diverse patient pool is expected to propel the demand for early phase clinical trial outsourcing market during the forecast period in the above mentioned region. Asia Pacific region is expected to be the moderately growing regional market.

Growing healthcare facilities, increased healthcare awareness, and conducive regulatory environment for conducting clinical trials in countries like Australia and China are mainly generating the demand for early phase clinical trials in the region.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Players

The players in early phase clinical trial outsourcingmarket include PRA Health Sciences,INC Research, ICON plc., QuintilesIMS, PAREXEL International Corporation., Chiltern International Ltd., Sofpromed, Covance Inc., Quanticate to name a few.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The report covers exhaustive analysis on

  • Early Phase Clinical Trial Outsourcing Market Segments
  • Early Phase Clinical Trial Outsourcing Market Dynamics
  • Early Phase Clinical Trial Outsourcing Market Size, 2016 - 2024
  • Early Phase Clinical Trial Outsourcing Market Size & Forecast 2017 to 2027
  • Early Phase Clinical Trial Outsourcing Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Early Phase Clinical Trial Outsourcing Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Early Phase Clinical Trial Outsourcing Market: Segmentation

Early phase clinical trial outsourcing market has been segmented on the basis of trail phase, services, end user and region.

Based on the trial phase, the early phase clinical trial outsourcing market is segmented into the following:

  • Phase 0
  • Phase 1
  • Phase 2

Based on the services, the early phase clinical trial outsourcing market is segmented into the following:

  • Regulatory Services
  • Clinical Data Management (CDM)
  • Medical Writing
  • Site Management
  • Pharmacovigilance (PV)
  • Risk-Based Monitoring
  • Bio statistical Services
  • Protocol Development

Based on end user, the early phase clinical trial outsourcing market is segmented into the following:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Drug Discovery Companies
  • Medical Devices Companies

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Formulation Development Outsourcing Market

Published : July 2022

Healthcare

Healthcare Regulatory Affairs Outsourcing Market

Published : December 2021

Google translate

Early Phase Clinical Trial Outsourcing Market